New multiple myeloma cell therapy yields dramatic results Hadassah Medical Center reports that trials of a groundbreaking CAR-T therapy showed a nearly 90% response rate in 74 patients.
Taking bisphosphonates? Read on Micromedic Technologies discovers new genetic markers to predict the risk of developing jaw necrosis from a certain class of drugs.